⌘K

Login Start Free

Home/Filings/4/0000899243-21-049425

4//SEC Filing

Appelbaum Kevin J 4

Accession 0000899243-21-049425

CIK 0001832415other

View on SEC.gov Company Profile

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 6:03 PM ET

Size

7.8 KB

Accession

0000899243-21-049425

Insider Transaction Report

Form 4

Period: 2021-12-20

Better Therapeutics, Inc.BTTX

Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amended

10% Owner

Transactions

Purchase
Common Stock
2021-12-20$4.60/sh+1,000$4,600→ 3,750 total

Holdings

Common Stock
(indirect: By Trust)
2,406,719

Appelbaum Kevin J

DirectorChief Executive Officer10% Owner

Transactions

Purchase
Common Stock
2021-12-20$4.60/sh+1,000$4,600→ 3,750 total

Holdings

Common Stock
(indirect: By Trust)
2,406,719

Footnotes (1)

[F1]These shares are owned directly by Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated May 16, 2020, as amended (the "Trust"), and indirectly by Mr. Appelbaum as trustee of the Trust. Mr. Appelbaum is an officer, director and ten percent owner of the Issuer.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Better Therapeutics, Inc.

CIK 0001832415

Entity typeother

Related Parties

1

filerCIK 0001547557

Filing Metadata

Form type: 4
Filed: Dec 21, 7:00 PM ET
Accepted: Dec 22, 6:03 PM ET
Size: 7.8 KB

View on SEC.gov